Penumbra, Inc. (PEN) Promotes Shruthi Narayan to President to Drive Global Growth

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Penumbra, Inc. is one of them.

Penumbra, Inc. (NYSE:PEN) based in California, is a global leader in thrombectomy and vascular intervention technologies, offering products such as the Indigo and Lightning series, as well as neuro and vascular embolization solutions. Operating in over 100 countries, the company serves acute stroke and broader vascular markets through both direct and distributor-driven channels.

In September 2025, Shruthi Narayan was promoted to President, bringing engineering and commercialization expertise to strengthen PEN’s focus on global innovation and market growth. The business also introduced the Ruby XL System, the largest and longest detachable embolization coil, demonstrating versatility in complex vascular procedures and supporting wider clinical adoption. These advances contribute to PEN’s reputation among the best healthcare stocks.

Expanding its thrombectomy capabilities, Penumbra, Inc. (NYSE:PEN) released the Lightning Bolt 6X device in a 150 cm length, enabling Computer Assisted Vacuum Thrombectomy (CAVT) in smaller, distal vessels, a critical advance for peripheral arterial disease interventions. Additionally, the firm completed enrollment for the STORM-PE Randomized Controlled Trial, evaluating CAVT’s effectiveness in pulmonary embolism, with results poised to influence future treatment guidelines and expand market penetration.

Looking ahead, Penumbra, Inc. (NYSE:PEN) remains committed to advancing minimally invasive clot removal technologies that improve patient outcomes while enhancing healthcare efficiency. The firm’s recent clinical data highlights the speed, safety, and efficacy of its CAVT devices, reinforcing growth potential in both U.S. and international markets.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.